Literature DB >> 25735796

Clinical analysis of fever of unknown origin in children: A 10-year experience in a northern Taiwan medical center.

Ching-Yi Cho1, Chou-Cheng Lai2, Ming-Luen Lee2, Chien-Lun Hsu2, Chun-Jen Chen2, Lo-Yi Chang2, Chiao-Wei Lo2, Sheng-Fong Chiang2, Keh-Gong Wu3.   

Abstract

BACKGROUND: Fever of unknown origin (FUO) was first described in 1961 as fever >38.3°C for at least 3 weeks with no apparent source after 1 week of investigations in the hospital. Infectious disease comprises the majority of cases (40-60%). There is no related research on FUO in children in Taiwan. The aim of this study is to determine the etiologies of FUO in children in Taiwan and to evaluate the relationship between the diagnosis and patient's demography and laboratory data.
METHODS: Children under 18 years old with fever >38.3°C for >2 weeks without apparent source after preliminary investigations at Taipei Veterans General Hospital during 2002-2012 were included. Fever duration, symptoms and signs, laboratory examinations, and final diagnosis were recorded. The distribution of etiologies and age, fever duration, laboratory examinations, and associated symptoms and signs were analyzed.
RESULTS: A total of 126 children were enrolled; 60 were girls and 66 were boys. The mean age was 6.7 years old. Infection accounted for 27.0% of cases, followed by undiagnosed cases (23.8%), miscellaneous etiologies (19.8%), malignancies (16.6%), and autoimmune disorders (12.7%). Epstein-Barr virus (EBV) and cytomegalovirus (CMV) were the most commonly found pathogens for infectious disease, and Kawasaki disease (KD) was the top cause of miscellaneous diagnosis.
CONCLUSIONS: Infectious disease remains the most common etiology. Careful history taking and physical examination are most crucial for making the diagnosis. Conservative treatment may be enough for most children with FUO, except for those suffering from malignancies.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Children; FUO; Fever of unknown origin; Infectious disease; Taiwan

Mesh:

Year:  2015        PMID: 25735796     DOI: 10.1016/j.jmii.2015.01.001

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  7 in total

Review 1.  Clinical perspectives and therapeutic strategies: pediatric autoinflammatory disease-a multi-faceted approach to fever of unknown origin of childhood.

Authors:  Akihiro Yachie
Journal:  Inflamm Regen       Date:  2022-07-02

2.  Anti-Epstein-Barr virus antibodies in Beijing during 2013-2017: What we have found in the different patients.

Authors:  Jingtao Cui; Wenjuan Yan; Shaoxia Xu; Qiaofeng Wang; Weihong Zhang; Wenjing Liu; Anping Ni
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

3.  Etiology and clinical characteristics of fever of unknown origin in children: a 15-year experience in a single center.

Authors:  Yi-Seul Kim; Kyung-Ran Kim; Ji-Man Kang; Jong-Min Kim; Yae-Jean Kim
Journal:  Korean J Pediatr       Date:  2017-03-27

4.  The impact of global budgeting in Taiwan on inpatients with unexplained fever.

Authors:  Keh-Sen Liu; Tsung-Fu Yu; Hsing-Ju Wu; Chun-Yi Lin
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

5.  Fever of unknown origin (FUO) in children: a single-centre experience from Beijing, China.

Authors:  Bing Hu; Tian-Ming Chen; Shu-Ping Liu; Hui-Li Hu; Ling-Yun Guo; He-Ying Chen; Shao-Ying Li; Gang Liu
Journal:  BMJ Open       Date:  2022-03-16       Impact factor: 2.692

6.  Immunoglobulin profiling identifies unique signatures in patients with Kawasaki disease during intravenous immunoglobulin treatment.

Authors:  Tai-Ming Ko; Kazuma Kiyotani; Jeng-Sheng Chang; Jae-Hyun Park; Poh Yin Yew; Yuan-Tsong Chen; Jer-Yuarn Wu; Yusuke Nakamura
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

7.  Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study.

Authors:  Toshio Naito; Mika Tanei; Nobuhiro Ikeda; Toshihiro Ishii; Tomio Suzuki; Hiroyuki Morita; Sho Yamasaki; Jun'ichi Tamura; Kenichiro Akazawa; Koji Yamamoto; Hiroshi Otani; Satoshi Suzuki; Motoo Kikuchi; Shiro Ono; Hiroyuki Kobayashi; Hozuka Akita; Susumu Tazuma; Jun Hayashi
Journal:  BMJ Open       Date:  2019-11-19       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.